NASDAQ:THRX
Theseus Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
theseusrx.comipo date
Oct 07, 2021
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also develops fourth-generation EGFR i...Show More
Earnings
Earnings Release in 14 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus